Swissmedic approves extension of booster dose to everyone aged 16 years and over
This clears the way for wider use of the booster vaccination. High risk individuals can still obtain a booster dose from age 12.
Swissmedic has reviewed the documentation submitted by the marketing authorisation holder last week and is adapting the product information. Individuals aged 16 years and over can now be administered a booster dose.
As stipulated in the Swissmedic decision of 26 October 2021, high risk individuals can still obtain the booster from age 12. In both cases, however, the second dose must have been administered at least six months previously.
Swissmedic reached this decision based, among other factors, on a study with 10,000 participants aged 16 to 87. The interim results of this study gave no indication of new risk aspects for the vaccine. Basic immunisation with Comirnaty involves two doses of 0.3 ml administered at an interval of three weeks.
The booster vaccination at least six months later that has now been approved can maintain protection against COVID-19 disease. ■